Acute Lymphoblastic Leukemia Clinical Trials
There are 11 registered clinical trials for Acute Lymphoblastic Leukemia in the TrialLens index.
Trials (11)
- Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic Leukemia N/A · Cairo University
- PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias Phase 1 · UNC Lineberger Comprehensive Cancer Center
- ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL N/A · Institute of Hematology & Blood Diseases Hospital, China
- Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer Phase 1/2 · Fred Hutchinson Cancer Center
- Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation Phase 2 · Fred Hutchinson Cancer Center
- Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation Phase 2 · Massachusetts General Hospital
- A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies Phase 1 · Guangdong Ruishun Biotech Co., Ltd
- Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL Phase 1 · Amgen
- Treatment of Childhood Acute Lymphoblastic Leukemia Phase 3 · Dana-Farber Cancer Institute
- Effect of Bovine Colostrum on Toxicity and Inflammatory Responses N/A · Steffen Husby
- Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Phase 1/2 · Amgen Research (Munich) GmbH
Related landscapes
- Phase 1/2 Acute Lymphoblastic Leukemia
- Phase 2 Acute Lymphoblastic Leukemia
- Phase 3 Acute Lymphoblastic Leukemia
- N/A Acute Lymphoblastic Leukemia
- Phase 1 Acute Lymphoblastic Leukemia
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.